SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-029611
Filing Date
2024-03-12
Accepted
2024-03-11 21:53:19
Documents
20
Period of Report
2024-03-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revb-20240312.htm   iXBRL 8-K 45234
2 EX-99.1 revb-ex99_1.htm EX-99.1 6214
3 EX-99.2 revb-ex99_2.htm EX-99.2 6523
4 GRAPHIC revb-ex99_1s1.jpg GRAPHIC 1687656
5 GRAPHIC revb-ex99_2s1.jpg GRAPHIC 336719
6 GRAPHIC revb-ex99_2s2.jpg GRAPHIC 679897
7 GRAPHIC revb-ex99_2s3.jpg GRAPHIC 570702
8 GRAPHIC revb-ex99_2s4.jpg GRAPHIC 484878
9 GRAPHIC revb-ex99_2s5.jpg GRAPHIC 543594
  Complete submission text file 0000950170-24-029611.txt   6145324

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20240312.xsd EX-101.SCH 48893
21 EXTRACTED XBRL INSTANCE DOCUMENT revb-20240312_htm.xml XML 6943
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 24740082
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)